*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Renal Impairment in Diabetes Mellitus Type2 In Iraq

Author: ALAA ABDULJABBAR ABDULRAZZAQ
Abstract: The present study was designed to investigate if there is any relation of inflammatory markers in the development and progression of renal impairment in diabetes mellitus type 2, so this study was conducted in the department of Biology, Al-Rasheed University College, comprising of n= 80 subjects known Diabetes mellitus patients with an age range 30 - 60 years and healthy controls n=80 with age range 30 - 60 years attending the national diabetes center for treatment. The study was aimed to quantitatively estimate the amount of serum urea, creatinine and IL-6 levels present in the blood, and evaluate their correlation in diabetic and non-diabetic subjects. The mean (± S.D.) serum urea level in the control group was found to be 24.95±10.88. whereas in diabetics, it was found to be 50.75±19.69. The mean (± S.D.) serum creatinine level in the control group was found to be 0.81±0.14 whereas in diabetics, it was found to be 1.40±0.87. The Il-6 in the control group was found to be 7.41 + 0.54 whereas in diabetes patient 10.66 + 1.16 thus, the mean levels of urea, creatinine and Il-6 was significantly higher in the diabetic subjects as compared to controls. So, the urea and creatinine and Il-6 is simple and useful biomarker which can serve as predictor tests for assessing kidney functions (nephropathy) in diabetic patients type2.
Keyword: Interleukin-6 (IL-6), urea, creatinine, ELISA, Diabetes mellitus, Biomarker, nephropathy, fasting blood glucose
DOI: https://doi.org/10.31838/ijpr/2020.12.01.329
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free